Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 73,781

Document Document Title
WO/2016/106988A1
Provided is a recombinant eukaryotic strain for producing taxadiene and a method for preparing taxadiene using same. The recombinant eukaryotic strain is obtained by introducing the following into the eukaryotic strain: a gene expression...  
WO/2016/107948A1
The present invention relates to the use of Lactobacillus rhamnosus in combination with Bifidobacterium longum to manufacture a formulation to increase male fertility in a subject. In particular, said strains are the strains Lactobacillu...  
WO/2016/108976A1
Compositions and methods include a new strain of Bacillus pumilus having plant growth promoting activity. In particular aspects, compositions containing the Bacillus pumilus strain can be applied alone or in combination with one or both ...  
WO/2016/108974A1
Compositions and methods for application to plants are provided for a new strain of Bacillus licheniformis RTI184 having plant growth promoting activity. Compositions and extracts of Bacillus licheniformis strains that include newly iden...  
WO/2016/106343A8
Aspects of the present disclosure relate to genetically engineered organisms useful for the diagnosis and treatment of inflammatory bowel disease.  
WO/2016/105483A1
Methods for increasing the genetic stability of genetically enhanced microbial host capable of producing a compound of interest are disclosed.  
WO/2016/101326A1
Provided are an oncolytic heterologous recombination Newcastle disease virus (NDV),preparation method and application thereof. The heterologous recombination NDV can express an alpha (1, 3) galactosyltransferase (alpha (1, 3) GT); the al...  
WO/2016/102853A1
The invention relates to an isolated strain of the Lactobacillus genus, characterised by its capacity to grow in the germination medium of a seed, and to limit the growth of bacteria such as Enterobactericaceae, more specifically E. coli...  
WO/2016/104437A1
A method that comprises culturing a C1 compound-assimilating bacterium and/or yeast, said bacterium and/or yeast being a methylotroph, using a medium containing a C1 compound and/or glycerol as a carbon source to thereby produce EGT.  
WO/2016/101720A1
Provided is a method for preparing Stallimycin. The method comprises: streptomycete ferments in a fermentation medium containing a carbon source, a nitrogen source and 3-hydroxy-4-amino-butyric acid, and vegetable oil is added to the fer...  
WO/2016/106343A1
Aspects of the present disclosure relate to genetically engineered organisms useful for the diagnosis and treatment of inflammatory bowel disease.  
WO/2016/095326A1
Provided is a construction method for OCH1-defective anti-CD20 tetravalent antibody expression Pichia pastoris, comprising: knocking out an OCH1 encoded α-1, 6-mannosyltransferase of a strain JC308; connecting the modified och1 with no ...  
WO/2016/097268A1
The invention relates to a genetically modified lactic acid bacterium capable of producing (S,S)-2,3-butanediol stereo specifically from glucose under aerobic conditions. Additionally the invention relates to a method for producing (S,S)...  
WO/2016/099917A1
The present invention relates in general to bacterial cells having genetic alterations that result in increased expression of a protein of interest and methods of making and using such cells. Aspects of the present invention include alte...  
WO/2016/094334A1
The invention provides a recombinant, carboxydotrophic Clostridium bacterium that expresses one or more of pyruvate:ferredoxin oxidoreductase (EC 1.2.7.1), acetolactate synthase (EC 2.2.1.6), and acetolactate decarboxylase (EC 4.1.1.5). ...  
WO/2016/092032A1
The invention relates to a probiotic strain selected from Lactobacillus reuteri V340 with accession number CECT 8605 and Bifidobacterium breve BT820 with accession number CECT 8606, or a variantof said probiotic strain having cholesterol...  
WO/2016/092201A1
The invention relates to a method for preserving microorganisms at ambient temperature, wherein: - a composition, referred to as the preservative composition, is prepared, said composition comprising the microorganisms to be preserved an...  
WO/2016/093450A1
The present invention relates to L. plantarum-K-1 BR (LP), which is lactobacillus that is separated from Kimchi and identified, the L. plantarum-K-1 BR (LP) exhibiting an anti-allergic effect; being capable of improved treatment of disea...  
WO/2016/090622A1
Provided are a hydroxyacyl-coenzyme A dehydrogenase gene and an acyl-coenzyme A thiolase gene, and a genetically-engineered bacteria and a use thereof. The hydroxyacyl-coenzyme A dehydrogenase gene encodes a protein (i) or (ii) as follow...  
WO/2016/090508A1
The invention relates to a microbiological method for the production of fluorescent, semiconductive nanoparticles (NPs) of copper sulphide, comprising the steps of: a) selecting a copper salt; b) growing a microorganism that tolerates th...  
WO/2016/090618A1
Provided are a biological metal corrosion inhibitor and a use thereof. The biological metal corrosion inhibitor contains Vibrio neocaledonicus sp., which can form a biological film with a metal corrosion inhibition effect on the surface ...  
WO/2016/090440A1
The development of attenuated live vaccines against salmonellosis has increased over the past years due to the nonexistence of completely effective vaccine formulations which enable different S. enterica serovars to be more effectively c...  
WO/2016/090556A1
Provided are a fungus-sourced high-temperature neutral Family-45 cellulase as well as a coding gene and an application thereof. The cellulase has the optimal pH value of 5.5 and the optimal temperature of 60°C, has certain enzyme activi...  
WO/2016/090343A1
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/090343A9
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/086554A1
Disclosed are a general monoclonal antibody for African swine fever virus strains as well as a preparation method therefor. The method comprises: immunizing a mouse by using a purified p54 immune protein, fusing spleen cells of the immun...  
WO/2016/087496A1
The present invention relates to the recombinant production of lipases in yeast. The present invention provides means and methods for improving the production of lipases in yeast.  
WO/2016/083450A3
Probiotic formulation comprising Lactobacillus plantarum TIFN 101, deposited under CBS138100, or a bacterial strain comprising a polynucleotide with at least 85% sequence identity to a polynucleotide from L.plantarum and use of the formu...  
WO/2016/085039A1
The present invention provides mixed strains for inhibiting seed germination of a weed plant consisting of Lactobacillus strains and yeast strains; a herbicide comprising the mixed strains, a culture of the strains or a concentrate of th...  
WO/2016/082305A1
Provided is a method for recombinant expression of β-glucosidase gene. Also provided is a recombinant expression vector comprising: (a) a coding sequence of an aspartic protease or active fragment thereof, (b) a coding sequence of β-gl...  
WO/2016/083450A2
The present invention relates to a new probiotic with immune modulating properties and to a new biomarker.  
WO/2016/082162A1
Lateral-flow assay and time-resolved fluorescence technologies provide a sensitive tool for detecting norovirus particles in a sample. A flow-through assay device employs norovirus and norovirus G2 antibodies. The lateral-flow assay incl...  
WO/2016/080665A1
The present invention provides a method for producing daptomycin comprising a step of culturing by adding, to a culture medium of a Streptomyces sp. Strain, decanoyl glyceride as a material of an n-decanoyl side chain. The method for pro...  
WO/2016/081239A1
The invention relates to a composition and methods for remediation of sulfate reducing bacteria (SRB) with newly discovered broad range bacteriocin recovered from oil and gas operation waste waters.  
WO/2016/081288A1
A process for refolding recombinant chymotrypsin produced from prokaryote host cells is described. In particular, the present invention provides a process for refolding recombinant chymotrypsin produced from E. coli is described.  
WO/2016/078466A1
The present invention provides a method for preparing an influenza virus hemagglutinin glycoprotein having a mammal sugar-type structure and no fucose. The method comprises: making influenza virus hemagglutinin HA gene express in a yeast...  
WO/2016/078553A1
Disclosed are a kit for detecting and typing dengue viruses by reverse transcription PCR and a detection method thereof. The kit for detecting and typing the dengue viruses by the reverse transcription PCR comprises primers, probes and a...  
WO/2016/081289A1
A process for producing recombinant trypsin from prokaryote host cells in high yield and high specific activity is described. In particular, a process for producing recombinant trypsin from E. coli is described.  
WO/2016/074409A1
Provided are a method for preparing vehicle biological fuel oil, biogas and fertilizer by utilizing a microalgae full composition, comprising the following steps: cultivation of algae; flocculation of algae; extraction of algae oil; prep...  
WO/2016/075294A1
The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral ab...  
WO/2016/074221A1
Provided are a spinosad heterologous expression strain construction method, a spinosad heterologous expression strain obtained by the method and use thereof in preparing the spinosad heterologous expression strain. The method utilizes a ...  
WO/2016/072655A1
The cassia seed lactic acid bacteria fermented product of the present invention has been used for a long time and thus is highly safe; is a herb medicine having low possibility of causing side effects; and exhibits an effect of increasin...  
WO/2016/071570A1
The present description is related to the field of cultivating algae. It introduces a method of cultivating algae by depleting the culture of an inorganic nutrient and exposing the alga to high intensity light to obtain algal cell mass h...  
WO/2016/072563A1
The present invention provides: a method capable of increasing the production of lipid by culturing diploid microalgae Chlamydomonas sp., obtained by treating haploid wild-type microalgae Chlamydomonas sp. with colcemid; a method for pro...  
WO/2016/065698A1
Provided are a saccharomyces cerevisiae strain CCTCC M 2014463 capable of being co-fermented by multiple carbon sources and an application thereof. The strain can adopt glucose, galactose, xylose, allulose, cane sugar, maltose, melibiose...  
WO/2016/065983A1
Provided in the present invention are a LAMP detection primer set and a reagent kit for a silkworm egg microsporidium. The primer set comprises outer primers Sep3F3/Sep3B3 and inner primers Sep3FIP/Sep3BIP, the sequences of which are as ...  
WO/2016/068656A2
The present invention relates to a gene expression system capable of producing psicose epimerase with high stability at a high expression rate, to transgenic generally recognized as safe (GRAS) microorganisms using the same, and to a met...  
WO/2016/068656A3
The present invention relates to a gene expression system capable of producing psicose epimerase with high stability at a high expression rate, to transgenic generally recognized as safe (GRAS) microorganisms using the same, and to a met...  
WO/2016/061827A1
The present invention relates to a biological degumming method for ramie. The method comprises the following steps: using bacillus (Bacillus sp. HG-28) as a strain; obtaining a degumming bacteria solution F used for biological degumming ...  
WO/2016/062232A1
The present invention provides a fermentation production process of L-sorbose with high concentration, using gluconobacter melanogenus as a production strain and usi-ng D-sorbitol as the substrate, adding 0.1 mg/ml-5 mg/ml of gelatin int...  

Matches 501 - 550 out of 73,781